×
Hero Background

Tonsil Cancer Companies

ID: MRFR/Pharma/2730-HCR
200 Pages
Rahul Gotadki
October 2025

Companies involved in addressing tonsil cancer typically operate in the pharmaceutical, biotechnology, and medical technology sectors. Tonsil cancer refers to the presence of cancerous cells in the tonsils, which are part of the lymphatic system. Treatment approaches for tonsil cancer may involve surgery, radiation therapy, chemotherapy, or a combination of these modalities.

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Tonsil Cancer Market Research Report - Global forecast till 2035 Infographic
Summary Table of Contents Segmentation Download PDF

Top Industry Leaders in the Tonsil Cancer Market

Tonsil Cancer Companies

 


Latest Tonsil Cancer Companies Update:

AstraZeneca Their anti-PD-1 immunotherapy drug, Imfinzi (durvalumab), received FDA approval for recurrent/metastatic head and neck squamous cell carcinoma, potentially providing a new treatment option for tonsil cancer patients.


Merck & Co.Their anti-PD-1 therapy, Keytruda (pembrolizumab), demonstrated promising results in clinical trials for advanced head and neck cancers, including tonsil cancer.


Medtronic Introduced their Hugo RAS robotic surgery system, offering potential for minimally invasive tonsillectomies in appropriate cases, reducing surgical risks and recovery times.


List of Tonsil Cancer Key companies in the market

  • F. Hoffmann-La Roche Ltd (Switzerland),

  • Amgen Inc. (US),

  • Novartis AG(Switzerland),

  • Abbott (US),

  • Beckman Coulter Inc. (US),

  • Debiopharm Group (Switzerland),

  • AbbVie Inc. (US),

  • Bayer AG (Germany)